Clinical Trials Directory

Trials / Terminated

TerminatedNCT00743197

Women With Chest Pain and Normal Coronary Arteries Study

Women With Chest Pain and Normal Coronary Arteries Study: A Randomized Study of Medical Treatment and Therapeutic Lifestyle Changes

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
3 (actual)
Sponsor
Northwestern University · Academic / Other
Sex
Female
Age
30 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare the effectiveness of standard medical therapy versus usual care in women with chest pain, coronary endothelial dysfunction and unblocked coronary arteries. Coronary endothelial dysfunction (CED) is a condition in which the layers of cells around the heart do not function properly and is believed to be key factor in the development of atherosclerosis (fat deposits in arteries). In addition, CED is associated with an increased risk for future cardiovascular events, such as heart attack and stroke. A coronary angiogram allows physicians to see if any of the arteries in the heart are blocked, usually by fatty plaque. In many instances, angiograms in women experiencing chest pain do not show evidence of coronary disease (free of significant plaque build-up). Currently, there is no standard of care treatment plan for patients with normal coronary arteries, despite symptoms of chest pain, and as a result these patients may not receive medical treatment. However, these women often return to their physicians more than once with chest pain and go through a similar battery of tests.

Detailed description

Endothelial function testing will be performed on women without significant coronary disease in order to help identify women who may be likely to develop coronary artery disease (CAD) and who would benefit from aggressive lifestyle (dietary counseling, exercise) or medical (treatment with aspirin and cholesterol and blood pressure lowering medications) interventions.

Conditions

Interventions

TypeNameDescription
DRUGAspirinAspirin 81 mg daily
DRUGLisinoprilLisinopril 10 mg every night
DRUGSimvastatinSimvastatin 20 mg every night
DRUGLovazaLovaza 1 gram daily
BEHAVIORALTherapeutic Lifestyle ChangesTherapeutic lifestyle changes will be initiated with the assistance of a dietician, including diet counseling, exercise recommendation, and weight maintenance/weight loss.

Timeline

Start date
2008-05-01
Primary completion
2010-05-01
Completion
2010-05-01
First posted
2008-08-28
Last updated
2023-12-12
Results posted
2011-11-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00743197. Inclusion in this directory is not an endorsement.